KraneShares MSCI All China Health Care Index ETF (KURE)
$19.25
▲ +0.46 (+2.44%)
1-day change
$17.60 – $19.50
52-week range
Holdings data is not available for this fund yet.
KURE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Sept. 30, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▲ +1.72% | ▲ +1.72% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▲ +2.78% | ▲ +2.78% |
Volatility 1Y·
Volatility 3Y·
Max drawdown 3Y
·
Beta 3Y·
Sharpe 1Y*·
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Last month (Jun 2026)
+$0
Quarter ending Jun 2026
-$3.3M
Trailing 12 months
-$12.8M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 63 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| BeOne Medicines AG | H0743H114 | $6.3M | 8.84 | 289,918 | EC | HK |
| INNOVENT BIOLOGICS, INC. | · | $6.3M | 8.80 | 617,500 | EC | HK |
| WUXI BIOLOGICS (CAYMAN) INC. | · | $5.4M | 7.51 | 1,212,635 | EC | HK |
| WuXi AppTec Co., Ltd. | · | $4.1M | 5.79 | 224,720 | EC | CN |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | · | $3.3M | 4.59 | 426,408 | EC | CN |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd | · | $3.0M | 4.27 | 152,155 | EC | CN |
| Akeso Inc | · | $2.6M | 3.72 | 236,000 | EC | HK |
| CSPC PHARMACEUTICAL GROUP LIMITED | · | $2.6M | 3.68 | 2,948,889 | EC | HK |
| Invesco Government & Agency Portfolio | 825252885 | $2.5M | 3.55 | 2,526,804 | STIV | US |
| SINO BIOPHARMACEUTICAL LIMITED | · | $2.4M | 3.39 | 4,287,750 | EC | HK |
| WuXi AppTec Co., Ltd. | · | $2.4M | 3.35 | 121,784 | EC | HK |
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | · | $2.0M | 2.85 | 538,000 | EC | HK |
| 3SBio Inc. | · | $1.8M | 2.49 | 822,500 | EC | HK |
| YUNNAN BAIYAO GROUP CO., LTD | · | $1.6M | 2.30 | 235,223 | EC | CN |
| Shanghai United Imaging Healthcare Co., Ltd. | · | $1.6M | 2.27 | 108,508 | EC | CN |
| Aier Eye Hospital Group Co., Ltd. | · | $1.5M | 2.10 | 1,227,963 | EC | CN |
| Sichuan Biokin Pharmaceutical Co Ltd | · | $1.4M | 1.97 | 32,322 | EC | CN |
| Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | · | $1.3M | 1.85 | 23,700 | EC | HK |
| ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. | · | $1.2M | 1.73 | 76,734 | EC | CN |
| SINOPHARM GROUP CO. LTD. | · | $1.2M | 1.67 | 586,800 | EC | HK |
| Sichuan Kelun Pharmaceutical Co., Ltd. | · | $1.1M | 1.55 | 194,015 | EC | CN |
| Haisco Pharmaceutical Group Co., Ltd. | · | $1.1M | 1.53 | 111,200 | EC | CN |
| HUADONG MEDICINE CO., LTD | · | $969K | 1.36 | 233,941 | EC | CN |
| WuXi XDC Cayman Inc | · | $964K | 1.35 | 132,500 | EC | HK |
| Shanghai Allist Pharmaceuticals Co Ltd | · | $954K | 1.34 | 59,328 | EC | CN |
| Legend Biotech Corp | 52490G102 | $909K | 1.28 | 31,488 | EC | US |
| RemeGen Co Ltd | · | $896K | 1.26 | 46,717 | EC | CN |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | · | $882K | 1.24 | 266,529 | EC | CN |
| Pharmaron Beijing Co., Ltd. | · | $818K | 1.15 | 191,875 | EC | CN |
| Shanghai Pharmaceuticals Holding Co., Ltd. | · | $807K | 1.13 | 355,812 | EC | CN |
| Genscript Biotech Corp | · | $792K | 1.11 | 508,000 | EC | HK |
| RemeGen Co Ltd | · | $748K | 1.05 | 79,000 | EC | HK |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | · | $731K | 1.03 | 220,711 | EC | CN |
| XtalPi Holdings Limited | · | $709K | 1.00 | 727,000 | EC | HK |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | · | $668K | 0.94 | 142,265 | EC | CN |
| Shenzhen New Industries Biomedical Engineering Co Ltd | · | $643K | 0.90 | 103,900 | EC | CN |
| BEIJING TONG REN TANG CO., LTD | · | $614K | 0.86 | 180,490 | EC | CN |
| Shanghai RAAS Blood Products Co., Ltd. | · | $560K | 0.79 | 876,134 | EC | CN |
| Chongqing Zhifei Biological Products Co., Ltd. | · | $543K | 0.76 | 315,472 | EC | CN |
| CSPC Innovation Pharmaceutical Co Ltd | · | $529K | 0.74 | 131,757 | EC | CN |
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | · | $527K | 0.74 | 53,708 | EC | CN |
| Imeik Technology Development Co Ltd | · | $512K | 0.72 | 39,840 | EC | CN |
| APT Medical Inc | · | $497K | 0.70 | 18,599 | EC | CN |
| Beijing Wantai Biological Pharmacy Enterprise Co Ltd | · | $479K | 0.67 | 120,442 | EC | CN |
| Hebei Changshan Biochemical Pharmaceutical Co Ltd | · | $402K | 0.56 | 116,500 | EC | CN |
| Hangzhou Tigermed Consulting Co., Ltd | · | $324K | 0.46 | 45,850 | EC | CN |
| ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. | · | $55K | 0.08 | 3,400 | EC | CN |
| Sichuan Kelun Pharmaceutical Co., Ltd. | · | $49K | 0.07 | 8,600 | EC | CN |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | · | $45K | 0.06 | 13,600 | EC | CN |
| Shanghai Pharmaceuticals Holding Co., Ltd. | · | $25K | 0.04 | 11,200 | EC | CN |
Dividends 6 payments
3.71%TTM yield
$0.72TTM payout / share
Annual
(est.)
| Ex-date | Amount / share |
|---|---|
| Dec. 22, 2025 | $0.7150 |
| Dec. 17, 2024 | $0.1840 |
| Dec. 18, 2023 | $0.1130 |
| Dec. 28, 2022 | $0.0100 |
| Dec. 29, 2021 | $4.0540 |
| Dec. 27, 2019 | $0.0570 |
Institutional owners (13F) 13 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| Varma Mutual Pension Insurance Co | $23,937,471 | 83.80% | 1,520,129 | Shares | June 30, 2026 |
| OLD MISSION CAPITAL LLC | $1,426,630 | 4.99% | 90,597 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,285,680 | 4.50% | 81,646 | Shares | June 30, 2026 |
| UBS Group AG | $809,223 | 2.83% | 51,389 | Shares | June 30, 2026 |
| Spire Wealth Management | $440,129 | 1.54% | 27,945 | Shares | June 30, 2026 |
| Saranac Partners Ltd | $304,405 | 1.07% | 19,331 | Shares | June 30, 2026 |
| BANK OF AMERICA CORP /DE/ | $223,607 | 0.78% | 14,200 | Shares | June 30, 2026 |
| MORGAN STANLEY | $82,042 | 0.29% | 5,210 | Shares | June 30, 2026 |
| Ascentis Wealth Management, LLC | $28,076 | 0.10% | 1,783 | Shares | June 30, 2026 |
| Financial Perspectives, Inc | $26,190 | 0.09% | 1,663 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $1,000 | 0.00% | 88 | Shares | June 30, 2026 |
| EverSource Wealth Advisors, LLC | $88 | 0.00% | 6 | Shares | June 30, 2026 |
| FMR LLC | $31 | 0.00% | 2 | Shares | June 30, 2026 |